STLNW
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst
NASDAQ · Healthcare · Medical - Care Facilities · US
$0.05
−23.33%Margins
Gross margin
15.7%
EBITDA margin
-3.3%
EBIT margin
-4.4%
Net margin
-6.2%
FCF margin
-0.6%
145.7%
Return on equity
-20.4%
Return on assets
-32.7%
Return on invested capital
3.39x
Asset turnover
$328.0K
Cash from operations
$0.41
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026